AnaptysBio, Inc(NASDAQ:ANAB) 
AnaptysBio, Inc., a clinical stage biotechnology company, engages in developing therapeutic product candidates for inflammation and immuno-oncology indications. The company's products include Imsidolimab, an IL-36R antibody that inhibits the interleukin-36 receptor for the treatment of various derma...
Website: http://www.anaptysbio.com
Founded: 2005
Full Time Employees: 89
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 18.67
H 19.36
L 18.06
C 18.51
V 837,653
10EMA 18.51
20EMA 18.51
60EMA 18.51
120EMA 18.51
250EMA 18.51